Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
49,078,070
-
Share change
-
+8,197,969
-
Total reported value
-
$121,713,810
-
Price per share
-
$2.48
-
Number of holders
-
74
-
Value change
-
+$24,164,999
-
Number of buys
-
41
-
Number of sells
-
26
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q4 2019
As of 31 Dec 2019,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,078,070 shares.
The largest 10 holders included
NEA Management Company, LLC, BVF INC/IL, WASATCH ADVISORS INC, VANGUARD GROUP INC, BlackRock Inc., Burrage Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, BOXER CAPITAL, LLC, Sio Capital Management, LLC, and STATE STREET CORP.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.